Teva Pharmaceuticals

Highly Commended: ESG Working Capital Initiative

Teva Pharmaceuticals was Highly Commended for an ESG working capital initiative that introduced sustainable supply chain finance (SCF) for the first time to small and medium-sized enterprises (SMEs) in Israel.

Judges described the programme – which gives Teva’s suppliers access to lower-cost financing based on an environmental, social and governance (ESG) score provided by independent sustainability ratings provider EcoVadis – as an “excellent best practice example” of ESG-linked SCF.

You have reached your monthly limit of articles. Register now for free unlimited access!
Login Join Now

Global sponsor